 Jeffrey Kaplan
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biofilms | 28 | 2016 | 232 | 7.280 |
Why?
| | Staphylococcus epidermidis | 12 | 2018 | 67 | 3.080 |
Why?
| | Polysaccharides, Bacterial | 11 | 2015 | 60 | 2.480 |
Why?
| | Aggregatibacter actinomycetemcomitans | 14 | 2015 | 21 | 2.440 |
Why?
| | Staphylococcus aureus | 7 | 2018 | 384 | 2.230 |
Why?
| | Bacterial Adhesion | 14 | 2018 | 83 | 2.020 |
Why?
| | Actinobacillus pleuropneumoniae | 5 | 2013 | 5 | 1.910 |
Why?
| | Anti-Bacterial Agents | 12 | 2018 | 1278 | 1.860 |
Why?
| | DNA, Bacterial | 6 | 2012 | 309 | 1.450 |
Why?
| | Adhesins, Bacterial | 6 | 2010 | 35 | 1.030 |
Why?
| | Bacterial Proteins | 14 | 2014 | 755 | 1.020 |
Why?
| | Prosthesis-Related Infections | 4 | 2011 | 74 | 1.010 |
Why?
| | Actinobacillus Infections | 5 | 2008 | 5 | 0.990 |
Why?
| | Kingella kingae | 2 | 2012 | 7 | 0.980 |
Why?
| | Extracellular Space | 2 | 2012 | 151 | 0.910 |
Why?
| | Povidone-Iodine | 2 | 2018 | 14 | 0.880 |
Why?
| | Deoxyribonuclease I | 4 | 2018 | 38 | 0.880 |
Why?
| | Acetylglucosamine | 4 | 2008 | 9 | 0.840 |
Why?
| | Staphylococcal Skin Infections | 1 | 2018 | 44 | 0.750 |
Why?
| | Cetylpyridinium | 4 | 2009 | 4 | 0.690 |
Why?
| | Microbial Sensitivity Tests | 6 | 2016 | 288 | 0.680 |
Why?
| | Amoxicillin | 1 | 2016 | 11 | 0.670 |
Why?
| | beta-Lactams | 2 | 2016 | 21 | 0.660 |
Why?
| | Glycoside Hydrolases | 7 | 2012 | 28 | 0.640 |
Why?
| | Pasteurellaceae | 3 | 2010 | 3 | 0.580 |
Why?
| | Genome, Bacterial | 2 | 2012 | 106 | 0.560 |
Why?
| | Exotoxins | 3 | 2008 | 16 | 0.550 |
Why?
| | Bacterial Capsules | 1 | 2013 | 26 | 0.540 |
Why?
| | Neisseriaceae Infections | 1 | 2012 | 6 | 0.510 |
Why?
| | Molecular Sequence Data | 12 | 2012 | 3115 | 0.500 |
Why?
| | Arthritis, Infectious | 1 | 2012 | 39 | 0.490 |
Why?
| | Extracellular Matrix | 2 | 2014 | 373 | 0.470 |
Why?
| | Drug Resistance, Bacterial | 4 | 2018 | 151 | 0.460 |
Why?
| | Recombination, Genetic | 1 | 2011 | 174 | 0.440 |
Why?
| | Enzyme Therapy | 1 | 2009 | 4 | 0.420 |
Why?
| | beta-Glucans | 1 | 2008 | 15 | 0.400 |
Why?
| | Haemophilus influenzae | 1 | 2009 | 32 | 0.400 |
Why?
| | Mouth | 2 | 2015 | 87 | 0.400 |
Why?
| | Disinfectants | 1 | 2009 | 30 | 0.390 |
Why?
| | Mouth Mucosa | 2 | 2007 | 95 | 0.380 |
Why?
| | Down-Regulation | 1 | 2011 | 681 | 0.370 |
Why?
| | Polysaccharides | 1 | 2008 | 79 | 0.370 |
Why?
| | Virulence Factors | 2 | 2008 | 132 | 0.360 |
Why?
| | Galactans | 1 | 2007 | 4 | 0.350 |
Why?
| | Genes, Bacterial | 2 | 2004 | 164 | 0.350 |
Why?
| | Drug Resistance | 1 | 2007 | 187 | 0.330 |
Why?
| | Aggressive Periodontitis | 2 | 2003 | 6 | 0.320 |
Why?
| | Swine Diseases | 1 | 2005 | 10 | 0.310 |
Why?
| | Bacteria | 2 | 2012 | 642 | 0.280 |
Why?
| | Acetylglucosaminidase | 1 | 2003 | 5 | 0.280 |
Why?
| | Neisseria | 1 | 2002 | 2 | 0.260 |
Why?
| | Bacteria, Anaerobic | 1 | 2002 | 24 | 0.250 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 182 | 0.250 |
Why?
| | Bacterial Physiological Phenomena | 2 | 2014 | 57 | 0.240 |
Why?
| | Sequence Analysis, DNA | 4 | 2009 | 804 | 0.240 |
Why?
| | Macrophages | 1 | 2008 | 1188 | 0.230 |
Why?
| | Recombinant Proteins | 4 | 2018 | 1464 | 0.230 |
Why?
| | Osteopontin | 1 | 2020 | 35 | 0.220 |
Why?
| | Chemokine CXCL10 | 1 | 2020 | 33 | 0.220 |
Why?
| | Polymerase Chain Reaction | 5 | 2008 | 1101 | 0.220 |
Why?
| | Microfluidics | 2 | 2010 | 43 | 0.220 |
Why?
| | Humans | 30 | 2020 | 109040 | 0.210 |
Why?
| | Polystyrenes | 3 | 2004 | 30 | 0.210 |
Why?
| | Animals | 15 | 2018 | 34587 | 0.200 |
Why?
| | Microfluidic Analytical Techniques | 2 | 2010 | 73 | 0.200 |
Why?
| | Sus scrofa | 1 | 2018 | 48 | 0.190 |
Why?
| | Species Specificity | 3 | 2011 | 648 | 0.180 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 21 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 196 | 0.180 |
Why?
| | Pancreatic Cyst | 1 | 2018 | 45 | 0.180 |
Why?
| | Neuroendocrine Tumors | 1 | 2018 | 61 | 0.180 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 241 | 0.170 |
Why?
| | Epithelial Cells | 3 | 2010 | 999 | 0.170 |
Why?
| | Liver | 2 | 2020 | 1855 | 0.170 |
Why?
| | Base Sequence | 4 | 2012 | 2322 | 0.170 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 325 | 0.160 |
Why?
| | Mutagenesis, Insertional | 3 | 2008 | 63 | 0.160 |
Why?
| | Pasteurellaceae Infections | 1 | 2015 | 1 | 0.150 |
Why?
| | Liver Neoplasms | 1 | 2019 | 480 | 0.150 |
Why?
| | DNA Transposable Elements | 3 | 2008 | 85 | 0.150 |
Why?
| | Escherichia coli | 3 | 2010 | 794 | 0.150 |
Why?
| | Acinetobacter baumannii | 1 | 2014 | 14 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2007 | 530 | 0.150 |
Why?
| | Periodontal Diseases | 1 | 2015 | 75 | 0.150 |
Why?
| | Air | 1 | 2014 | 57 | 0.150 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 86 | 0.140 |
Why?
| | Bone Resorption | 1 | 2015 | 87 | 0.140 |
Why?
| | Anilides | 1 | 2014 | 75 | 0.140 |
Why?
| | Plankton | 1 | 2014 | 8 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2014 | 64 | 0.140 |
Why?
| | Biopsy | 1 | 2018 | 1081 | 0.140 |
Why?
| | Surface Properties | 4 | 2012 | 430 | 0.130 |
Why?
| | Molecular Weight | 1 | 2013 | 353 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2011 | 2256 | 0.130 |
Why?
| | Coated Materials, Biocompatible | 1 | 2012 | 64 | 0.120 |
Why?
| | Tobramycin | 1 | 2011 | 40 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2018 | 3843 | 0.120 |
Why?
| | Cell Communication | 1 | 2013 | 260 | 0.120 |
Why?
| | Cell Survival | 3 | 2012 | 1153 | 0.120 |
Why?
| | Genetic Complementation Test | 2 | 2008 | 66 | 0.110 |
Why?
| | Culture Media | 3 | 2010 | 171 | 0.110 |
Why?
| | Orthopedic Equipment | 1 | 2010 | 7 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 693 | 0.110 |
Why?
| | Pyridines | 1 | 2014 | 465 | 0.110 |
Why?
| | Treatment Failure | 1 | 2011 | 332 | 0.110 |
Why?
| | Focal Nodular Hyperplasia | 1 | 2010 | 2 | 0.110 |
Why?
| | Escherichia coli Proteins | 1 | 2011 | 162 | 0.110 |
Why?
| | Fungi | 1 | 2011 | 114 | 0.110 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2007 | 54 | 0.110 |
Why?
| | Titanium | 1 | 2010 | 68 | 0.100 |
Why?
| | Mutation | 5 | 2009 | 3257 | 0.100 |
Why?
| | Osteoblasts | 1 | 2010 | 104 | 0.100 |
Why?
| | Sodium Hypochlorite | 1 | 2009 | 5 | 0.100 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2009 | 23 | 0.100 |
Why?
| | Convection | 1 | 2008 | 7 | 0.100 |
Why?
| | DNA Primers | 2 | 2007 | 603 | 0.100 |
Why?
| | Chlorhexidine | 1 | 2009 | 28 | 0.100 |
Why?
| | Colony Count, Microbial | 1 | 2009 | 87 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2011 | 277 | 0.100 |
Why?
| | Azo Compounds | 1 | 2008 | 25 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2010 | 159 | 0.100 |
Why?
| | Enzymes | 1 | 2009 | 77 | 0.100 |
Why?
| | Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2008 | 2 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 517 | 0.100 |
Why?
| | Diffusion | 1 | 2008 | 124 | 0.100 |
Why?
| | Periodontitis | 2 | 2006 | 51 | 0.090 |
Why?
| | Phylogeny | 2 | 2002 | 782 | 0.090 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2007 | 7 | 0.090 |
Why?
| | Congo Red | 1 | 2007 | 11 | 0.090 |
Why?
| | Gene Order | 1 | 2007 | 28 | 0.090 |
Why?
| | Tritium | 1 | 2007 | 76 | 0.090 |
Why?
| | Detergents | 1 | 2007 | 52 | 0.090 |
Why?
| | Chromosomes, Bacterial | 1 | 2007 | 8 | 0.090 |
Why?
| | Ampicillin | 1 | 2007 | 13 | 0.090 |
Why?
| | Glycosyltransferases | 1 | 2007 | 10 | 0.090 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 367 | 0.090 |
Why?
| | Glycogen Storage Disease Type IV | 1 | 2006 | 4 | 0.090 |
Why?
| | 1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 4 | 0.090 |
Why?
| | Genetic Variation | 2 | 2002 | 986 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2008 | 2208 | 0.080 |
Why?
| | Hydrogels | 2 | 2012 | 514 | 0.080 |
Why?
| | Pleuropneumonia | 1 | 2005 | 1 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 2836 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2006 | 176 | 0.080 |
Why?
| | Gene Deletion | 1 | 2007 | 395 | 0.070 |
Why?
| | Female | 8 | 2020 | 61540 | 0.070 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 58 | 0.070 |
Why?
| | Primates | 1 | 2005 | 107 | 0.070 |
Why?
| | Lactoferrin | 1 | 2003 | 29 | 0.070 |
Why?
| | Male | 9 | 2020 | 60099 | 0.070 |
Why?
| | O Antigens | 1 | 2003 | 8 | 0.070 |
Why?
| | Liver Transplantation | 1 | 2010 | 756 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 570 | 0.070 |
Why?
| | Catheterization | 1 | 2004 | 192 | 0.070 |
Why?
| | Agar | 1 | 2002 | 10 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1998 | 0.060 |
Why?
| | Swine | 1 | 2005 | 661 | 0.060 |
Why?
| | Bacteriological Techniques | 1 | 2003 | 62 | 0.060 |
Why?
| | Middle Aged | 6 | 2020 | 28504 | 0.060 |
Why?
| | Serotyping | 1 | 2002 | 31 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2003 | 448 | 0.060 |
Why?
| | DNA, Ribosomal | 1 | 2002 | 87 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2009 | 1267 | 0.060 |
Why?
| | Adult | 6 | 2020 | 31401 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2003 | 375 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 2002 | 109 | 0.060 |
Why?
| | Mice | 4 | 2014 | 14929 | 0.060 |
Why?
| | Phenotype | 2 | 2010 | 2968 | 0.060 |
Why?
| | Kinetics | 1 | 2004 | 1762 | 0.050 |
Why?
| | Coculture Techniques | 2 | 2010 | 211 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2002 | 467 | 0.050 |
Why?
| | Temperature | 1 | 2002 | 641 | 0.050 |
Why?
| | Models, Biological | 1 | 2007 | 1867 | 0.050 |
Why?
| | Infant | 1 | 2012 | 7791 | 0.050 |
Why?
| | ROC Curve | 1 | 2020 | 485 | 0.050 |
Why?
| | Transcription, Genetic | 2 | 2020 | 1461 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2010 | 2090 | 0.050 |
Why?
| | Carcinoembryonic Antigen | 1 | 2018 | 35 | 0.050 |
Why?
| | Cyst Fluid | 1 | 2018 | 27 | 0.050 |
Why?
| | Surgical Instruments | 1 | 2018 | 46 | 0.040 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 53 | 0.040 |
Why?
| | Cell Movement | 1 | 2002 | 912 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6708 | 0.040 |
Why?
| | Endosonography | 1 | 2018 | 137 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1128 | 0.040 |
Why?
| | Transcriptome | 1 | 2020 | 575 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2018 | 693 | 0.040 |
Why?
| | Binding Sites | 2 | 2010 | 1315 | 0.040 |
Why?
| | Monosaccharides | 1 | 2014 | 12 | 0.040 |
Why?
| | HCT116 Cells | 1 | 2014 | 74 | 0.040 |
Why?
| | Cell Line | 2 | 2012 | 2967 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 69 | 0.040 |
Why?
| | Aged | 3 | 2019 | 19745 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1930 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 178 | 0.030 |
Why?
| | Microscopy | 1 | 2014 | 115 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 3196 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2433 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 673 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 280 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2014 | 218 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 339 | 0.030 |
Why?
| | Polymethacrylic Acids | 1 | 2012 | 62 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3323 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 449 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 755 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2009 | 1632 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1540 | 0.030 |
Why?
| | Propidium | 1 | 2010 | 5 | 0.030 |
Why?
| | 3T3 Cells | 1 | 2010 | 161 | 0.030 |
Why?
| | Cell Shape | 1 | 2010 | 54 | 0.030 |
Why?
| | Cohort Studies | 1 | 2020 | 4802 | 0.030 |
Why?
| | Rats | 2 | 2015 | 6616 | 0.030 |
Why?
| | Siphoviridae | 1 | 2009 | 2 | 0.030 |
Why?
| | Bacteriophage T7 | 1 | 2009 | 4 | 0.030 |
Why?
| | Artificial Gene Fusion | 1 | 2009 | 5 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2598 | 0.030 |
Why?
| | Plasmids | 1 | 2010 | 383 | 0.030 |
Why?
| | Protein Hydrolysates | 1 | 2008 | 7 | 0.020 |
Why?
| | Caseins | 1 | 2008 | 24 | 0.020 |
Why?
| | Child | 2 | 2010 | 16571 | 0.020 |
Why?
| | Buffers | 1 | 2008 | 79 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 113 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2010 | 447 | 0.020 |
Why?
| | Adolescent | 2 | 2010 | 18184 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 294 | 0.020 |
Why?
| | Orthopedics | 1 | 2010 | 144 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2008 | 213 | 0.020 |
Why?
| | Rifampin | 1 | 2008 | 67 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 925 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 446 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2014 | 987 | 0.020 |
Why?
| | Cercopithecidae | 1 | 2007 | 6 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 120 | 0.020 |
Why?
| | Hemolysis | 1 | 2008 | 132 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 370 | 0.020 |
Why?
| | Hydrolysis | 1 | 2007 | 179 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 174 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 7082 | 0.020 |
Why?
| | Sodium Chloride | 1 | 2008 | 171 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 419 | 0.020 |
Why?
| | Cyclic AMP | 1 | 2008 | 297 | 0.020 |
Why?
| | Abortion, Eugenic | 1 | 2006 | 2 | 0.020 |
Why?
| | Knee Prosthesis | 1 | 2006 | 16 | 0.020 |
Why?
| | Hip Prosthesis | 1 | 2006 | 36 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 414 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 454 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 401 | 0.020 |
Why?
| | Tissue Engineering | 1 | 2010 | 318 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2007 | 405 | 0.020 |
Why?
| | Genome Components | 1 | 2006 | 1 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 541 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 528 | 0.020 |
Why?
| | Fimbriae, Bacterial | 1 | 2006 | 19 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2007 | 586 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 311 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 450 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 157 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2012 | 1749 | 0.020 |
Why?
| | Spodoptera | 1 | 2003 | 46 | 0.020 |
Why?
| | Genetic Testing | 1 | 2006 | 375 | 0.020 |
Why?
| | Calcium | 1 | 2010 | 1181 | 0.020 |
Why?
| | Maxilla | 1 | 2003 | 35 | 0.020 |
Why?
| | Computer Simulation | 1 | 2008 | 951 | 0.020 |
Why?
| | Alveolar Bone Loss | 1 | 2003 | 32 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2003 | 598 | 0.020 |
Why?
| | Virulence | 1 | 2003 | 244 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2003 | 174 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2010 | 2343 | 0.020 |
Why?
| | Iron | 1 | 2003 | 233 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1591 | 0.010 |
Why?
| | Signal Transduction | 1 | 2014 | 4839 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 787 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1404 | 0.010 |
Why?
| | Genotype | 1 | 2003 | 2072 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2006 | 4852 | 0.010 |
Why?
| | Child, Preschool | 1 | 2010 | 9406 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 5004 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2006 | 1631 | 0.010 |
Why?
|
|
Kaplan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|